Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy

被引：0
|
作者：
Cormack, J [1 ]
机构：
[1] Flinders Med Ctr, Div Med Imaging, Bedford Pk, SA 5042, Australia
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1998年 / 25卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：442 / 442
页数：1
相关论文
共 50 条
  • [1] Radiation doses deriving from patients undergoing 111In-DTPA-d-Phe-1-octreotide scintigraphy
    Amir Kurtaran
    Josef Pfreitfellner
    Peter Schaffarich
    Peter Smith-Jones
    Bruno Niederle
    Markus Raderer
    Irene Virgolini
    Helmar Bergmann
    Ernst Havlik
    European Journal of Nuclear Medicine, 1997, 24 : 1298 - 1300
  • [2] Radiation doses deriving from patients undergoing 111In-DTPA-D-Phe-1-octreotide scintigraphy -: Reply
    Smith-Jones, PM
    Havlik, E
    Kurtaran, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (04): : 443 - 444
  • [3] Radiation doses deriving from patients undergoing In-111-DTPA-D-Phe-1-octreotide scintigraphy
    Kurtaran, A
    Pfreitfellner, J
    Schaffarich, P
    SmithJones, P
    Niederle, B
    Raderer, M
    Virgolini, I
    Bergmann, H
    Havlik, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (10) : 1298 - 1300
  • [4] Optimization of doses received by the hospital staff and the members of the family of patients undergoing 111In-DTPA-D-Phe1-Octreotide therapy
    Kontogeorgakos, D.
    Limouris, G. S.
    Kamenopoulou, V.
    Carinou, E.
    Papanikolos, G.
    Vlahos, L.
    Dimitriou, P.
    RADIATION PROTECTION DOSIMETRY, 2007, 125 (1-4) : 403 - 406
  • [5] Distribution and elimination characteristics of111In-DTPA-D-Phe1-octreotide and111In-DTPA-L-Phe1-octreotide in rats
    Alice Laznickova
    M. Laznicek
    F. Trejtnar
    L. Melicharova
    Kazuko Horuichi Suzuki
    Hiromichi Akizawa
    Yasushi Arano
    Akira Yokoyama
    European Journal of Drug Metabolism and Pharmacokinetics, 2002, 27 : 37 - 43
  • [6] Distribution and elimination characteristics of 111In-DTPA-D-Phe1-octreotide and 111In-DTPA-L-Phe1-octreotide in rats
    Laznickova, A
    Laznicek, M
    Trejtnar, F
    Melicharova, L
    Suzuki, KH
    Akizawa, H
    Arano, Y
    Yokoyama, A
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2002, 27 (01) : 37 - 43
  • [7] Functional imaging of langerhans cell histiocytosis by 111In-DTPA-D-Phe1-octreotide scintigraphy
    Lastoria, S
    Montella, L
    Catalano, L
    Rotoli, B
    Muto, P
    Palmieri, G
    CANCER, 2002, 94 (03) : 633 - 640
  • [8] LOCALIZATION OF METASTATIC GASTROENTEROPANCREATIC TUMORS BY SOMATOSTATIN RECEPTOR SCINTIGRAPHY WITH [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
    HAMMOND, PJ
    ARKA, A
    PETERS, AM
    BLOOM, SR
    GILBEY, SG
    QUARTERLY JOURNAL OF MEDICINE, 1994, 87 (02): : 83 - 88
  • [9] In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy
    Lastoria, S
    Vergara, E
    Palmieri, G
    Acampa, W
    Varrella, P
    Caracò, C
    Bianco, RA
    Muto, P
    Salvatore, M
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (04) : 634 - 639
  • [10] SOMATOSTATIN RECEPTOR SCINTIGRAPHY OF CARCINOID-TUMORS USING THE [IN-111-DTPA-D-PHE(1)]-OCTREOTIDE
    WESTLIN, JE
    JANSON, ET
    ARNBERG, H
    AHLSTROM, H
    OBERG, K
    NILSSON, S
    ACTA ONCOLOGICA, 1993, 32 (7-8) : 783 - 786
12345